However, the previous works suffered from a lack of specific targeting for cancer cells and the instability of the p53 protein because of the actions of multiple E3 ubiquitin ligases, including Mdm2 and ARF-BP1/Mule [11]. This evidence concerns the gene TP53 and cancer.